{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:57:38Z","timestamp":1792720658687,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T00:00:00Z","timestamp":1448409600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["ITN - FP7 - Marie Curie Action - 264361"],"award-info":[{"award-number":["ITN - FP7 - Marie Curie Action - 264361"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["ITN - FP7 - Marie Curie Action - 264361"],"award-info":[{"award-number":["ITN - FP7 - Marie Curie Action - 264361"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13058-015-0652-6","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T08:42:43Z","timestamp":1448440963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features"],"prefix":"10.1186","volume":"17","author":[{"given":"Andrea","family":"Aloia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeniya","family":"Petrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Tomiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Bissels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"D\u00e9as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska Maria","family":"Zickgraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Spaich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"S\u00fctterlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schneeweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Reitberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"R\u00fcberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Gerstmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Agorku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kn\u00f6bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Terranegra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Falleni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Soldati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Ronald","family":"Sprick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Trumpp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Gabriel","family":"Judde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Hardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,25]]},"reference":[{"issue":"4","key":"652_CR1","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.ajpath.2013.08.002","volume":"183","author":"AG Rivenbark","year":"2013","unstructured":"Rivenbark AG, O\u2019Connor SM, Coleman WB. Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine. Am J Pathol. 2013;183(4):1113\u201324.","journal-title":"Am J Pathol"},{"issue":"25","key":"652_CR2","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1200\/JCO.2013.54.1870","volume":"32","author":"F Ades","year":"2014","unstructured":"Ades F, Zardavas D, Bozovic-Spasojevic I, Pugliano L, Fumagalli D, de Azambuja E, et al. Luminal B breast cancer: molecular characterization, clinical management, and future perspectives. J Clin Oncol. 2014;32(25):2794\u2013803.","journal-title":"J Clin Oncol"},{"issue":"18","key":"652_CR3","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1016\/j.ejca.2008.09.034","volume":"44","author":"WJ Irvin Jr","year":"2008","unstructured":"Irvin Jr WJ, Carey LA. What is triple-negative breast cancer? Eur J Cancer. 2008;44(18):2799\u2013805.","journal-title":"Eur J Cancer"},{"issue":"3","key":"652_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1177\/1758834013519843","volume":"6","author":"SL Davis","year":"2014","unstructured":"Davis SL, Eckhardt SG, Tentler JJ, Diamond JR. Triple-negative breast cancer: bridging the gap from cancer genomics to predictive biomarkers. Ther Adv Med Oncol. 2014;6(3):88\u2013100.","journal-title":"Ther Adv Med Oncol"},{"issue":"8","key":"652_CR5","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","volume":"26","author":"C Liedtke","year":"2008","unstructured":"Liedtke C, Mazouni C, Hess KR, Andre F, Tordai A, Mejia JA, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol. 2008;26(8):1275\u201381.","journal-title":"J Clin Oncol"},{"issue":"1","key":"652_CR6","first-page":"58","volume":"9","author":"B Weigelt","year":"2011","unstructured":"Weigelt B, Pusztai L, Ashworth A, Reis-Filho JS. Challenges translating breast cancer gene signatures into the clinic. Nat Rev. 2011;9(1):58\u201364.","journal-title":"Nat Rev"},{"issue":"2","key":"652_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.canlet.2012.06.010","volume":"325","author":"O Hardt","year":"2012","unstructured":"Hardt O, Wild S, Oerlecke I, Hofmann K, Luo S, Wiencek Y, et al. Highly sensitive profiling of CD44+\/CD24\u2212 breast cancer stem cells by combining global mRNA amplification and next generation sequencing: evidence for a hyperactive PI3K pathway. Cancer Lett. 2012;325(2):165\u201374.","journal-title":"Cancer Lett"},{"issue":"4\u20135","key":"652_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.drup.2008.07.001","volume":"11","author":"M Sabbah","year":"2008","unstructured":"Sabbah M, Emami S, Redeuilh G, Julien S, Pr\u00e9vost G, Zimber A, et al. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updat. 2008;11(4\u20135):123\u201351.","journal-title":"Drug Resist Updat"},{"issue":"13","key":"652_CR9","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1158\/1078-0432.CCR-07-0078","volume":"13","author":"E Marangoni","year":"2007","unstructured":"Marangoni E, Vincent-Salomon A, Auger N, Degeorges A, Assayag F, de Cremoux P, et al. A new model of patient tumor-derived breast cancer xenografts for preclinical assays. Clin Cancer Res. 2007;13(13):3989\u201398.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"652_CR10","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/nm.2454","volume":"17","author":"YS DeRose","year":"2011","unstructured":"DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, Ebbert MT, et al. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med. 2011;17(11):1514\u201320.","journal-title":"Nat Med"},{"issue":"7537","key":"652_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/518027a","volume":"518","author":"A Bradbury","year":"2015","unstructured":"Bradbury A, Pluckthun A. Reproducibility: standardize antibodies used in research. Nature. 2015;518(7537):27\u20139.","journal-title":"Nature"},{"issue":"7547","key":"652_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/520295b","volume":"520","author":"AM Bradbury","year":"2015","unstructured":"Bradbury AM, Pluckthun A. Antibodies: validate recombinants once. Nature. 2015;520(7547):295.","journal-title":"Nature"},{"issue":"Database issue","key":"652_CR13","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets\u2014update. Nucleic Acids Res. 2013;41(Database issue):D991\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"652_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207\u201310.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"652_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gy\u00f6rffy","year":"2010","unstructured":"Gy\u00f6rffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010;123(3):725\u201331.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"652_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1530\/ERC-11-0329","volume":"19","author":"B Gy\u00f6rffy","year":"2012","unstructured":"Gy\u00f6rffy B, L\u00e1nczky A, Sz\u00e1ll\u00e1si Z. Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. Endocr Relat Cancer. 2012;19(2):197\u2013208.","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"652_CR17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ncponc1110","volume":"5","author":"A Trumpp","year":"2008","unstructured":"Trumpp A, Wiestler OD. Mechanisms of disease: cancer stem cells\u2014targeting the evil twin. Nat Clin Pract. 2008;5(6):337\u201347.","journal-title":"Nat Clin Pract"},{"issue":"26","key":"652_CR18","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1056\/NEJMp1205737","volume":"366","author":"TM Prowell","year":"2012","unstructured":"Prowell TM, Pazdur R. Pathological complete response and accelerated drug approval in early breast cancer. N Engl J Med. 2012;366(26):2438\u201341.","journal-title":"N Engl J Med"},{"issue":"6","key":"652_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nbt.2576","volume":"31","author":"I Baccelli","year":"2013","unstructured":"Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V, et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol. 2013;31(6):539\u201344.","journal-title":"Nat Biotechnol"},{"key":"652_CR20","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1038\/srep03494","volume":"3","author":"SQ Wong","year":"2013","unstructured":"Wong SQ, Li J, Salemi R, Sheppard KE, Do H, Tothill RW, et al. Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours. Sci Rep. 2013;3:3494.","journal-title":"Sci Rep."},{"issue":"1","key":"652_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene Ontology: tool for the unification of biology. Nat Genet. 2000;25(1):25\u20139.","journal-title":"Nat Genet"},{"issue":"29","key":"652_CR22","doi-asserted-by":"publisher","first-page":"26474","DOI":"10.1074\/jbc.M213223200","volume":"278","author":"S Saito","year":"2003","unstructured":"Saito S, Aoki H, Ito A, Ueno S, Wada T, Mitsuzuka K, et al. Human \u03b12,3-sialyltransferase (ST3Gal II) is a stage-specific embryonic antigen-4 synthase. J Biol Chem. 2003;278(29):26474\u20139.","journal-title":"J Biol Chem"},{"issue":"10","key":"652_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045647","volume":"7","author":"GV Hegde","year":"2012","unstructured":"Hegde GV, de la Cruz C, Eastham-Anderson J, Zheng Y, Sweet-Cordero EA, Jackson EL. Residual tumor cells that drive disease relapse after chemotherapy do not have enhanced tumor initiating capacity. PLoS One. 2012;7(10), e45647.","journal-title":"PLoS One"},{"issue":"9","key":"652_CR24","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1158\/1541-7786.MCR-14-0105","volume":"12","author":"RC D\u2019Angelo","year":"2014","unstructured":"D\u2019Angelo RC, Liu XW, Najy AJ, Jung YS, Won J, Chai KX, et al. TIMP-1 via TWIST1 induces EMT phenotypes in human breast epithelial cells. Mol Cancer Res. 2014;12(9):1324\u201333.","journal-title":"Mol Cancer Res"},{"issue":"23","key":"652_CR25","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMra043172","volume":"353","author":"HT Cohen","year":"2005","unstructured":"Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med. 2005;353(23):2477\u201390.","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"652_CR26","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1038\/sj.bjc.6601494","volume":"89","author":"WP McGuire 3rd","year":"2003","unstructured":"McGuire 3rd WP, Markman M. Primary ovarian cancer chemotherapy: current standards of care. Br J Cancer. 2003;89 Suppl 3:S3\u20138.","journal-title":"Br J Cancer"},{"issue":"7","key":"652_CR27","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100(7):3983\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7123","key":"652_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature05384","volume":"445","author":"L Ricci-Vitiani","year":"2007","unstructured":"Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007;445(7123):111\u20135.","journal-title":"Nature"},{"issue":"11","key":"652_CR29","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","volume":"68","author":"S Zhang","year":"2008","unstructured":"Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 2008;68(11):4311\u201320.","journal-title":"Cancer Res"},{"key":"652_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/B978-0-12-394274-6.00003-0","volume":"117","author":"YY Liu","year":"2013","unstructured":"Liu YY, Hill RA, Li YT. Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance. Adv Cancer Res. 2013;117:59\u201389.","journal-title":"Adv Cancer Res."},{"issue":"15","key":"652_CR31","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.1158\/1078-0432.CCR-10-2538","volume":"17","author":"M Maugeri-Sacca","year":"2011","unstructured":"Maugeri-Sacca M, Vigneri P, De Maria R. Cancer stem cells and chemosensitivity. Clin Cancer Res. 2011;17(15):4942\u20137.","journal-title":"Clin Cancer Res"},{"key":"652_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fonc.2014.00002","volume":"4","author":"L Zinzi","year":"2014","unstructured":"Zinzi L, Capparelli E, Cantore M, Contino M, Leopoldo M, Colabufo NA. Small and innovative molecules as new strategy to revert MDR. Front Oncol. 2014;4:2.","journal-title":"Front Oncol."},{"key":"652_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1476-4598-9-145","volume":"9","author":"YY Liu","year":"2010","unstructured":"Liu YY, Gupta V, Patwardhan GA, Bhinge K, Zhao Y, Bao J, et al. Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and \u03b2-catenin signaling. Mol Cancer. 2010;9:145.","journal-title":"Mol Cancer."},{"issue":"7","key":"652_CR34","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1083\/jcb.200601018","volume":"172","author":"JM Lee","year":"2006","unstructured":"Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 2006;172(7):973\u201381.","journal-title":"J Cell Biol"},{"issue":"9","key":"652_CR35","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2174\/15680096113136660097","volume":"13","author":"Y Shang","year":"2013","unstructured":"Shang Y, Cai X, Fan D. Roles of epithelial-mesenchymal transition in cancer drug resistance. Curr Cancer Drug Targets. 2013;13(9):915\u201329.","journal-title":"Curr Cancer Drug Targets"},{"issue":"8","key":"652_CR36","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/emmm.201302827","volume":"5","author":"FA Siebzehnrubl","year":"2013","unstructured":"Siebzehnrubl FA, Silver DJ, Tugertimur B, Deleyrolle LP, Siebzehnrubl D, Sarkisian MR, et al. The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol Med. 2013;5(8):1196\u2013212.","journal-title":"EMBO Mol Med"},{"issue":"6","key":"652_CR37","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.ccr.2012.11.009","volume":"22","author":"T Brabletz","year":"2012","unstructured":"Brabletz T. EMT and MET in metastasis: where are the cancer stem cells? Cancer Cell. 2012;22(6):699\u2013701.","journal-title":"Cancer Cell"},{"issue":"4","key":"652_CR38","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1172\/JCI42579","volume":"121","author":"Y Yang","year":"2011","unstructured":"Yang Y, Ahn YH, Gibbons DL, Zang Y, Lin W, Thilaganathan N, et al. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. J Clin Invest. 2011;121(4):1373\u201385.","journal-title":"J Clin Invest"},{"issue":"12","key":"652_CR39","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1038\/nm.2512","volume":"17","author":"B Mateescu","year":"2011","unstructured":"Mateescu B, Batista L, Cardon M, Gruosso T, de Feraudy Y, Mariani O, et al. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med. 2011;17(12):1627\u201335.","journal-title":"Nat Med"},{"issue":"4","key":"652_CR40","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc2620","volume":"9","author":"K Polyak","year":"2009","unstructured":"Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9(4):265\u201373.","journal-title":"Nat Rev Cancer"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-015-0652-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13058-015-0652-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-015-0652-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-015-0652-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T18:39:57Z","timestamp":1567363197000},"score":1,"resource":{"primary":{"URL":"http:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-015-0652-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,25]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["652"],"URL":"https:\/\/doi.org\/10.1186\/s13058-015-0652-6","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,25]]},"article-number":"146"}}